Challenges to the Access and Utilization of Corneal Cross-Linking in Patients With Keratoconus in the United States

Study limitation reported by the research below: “Photrexa phase-out date cited as 2026; given today's date (September 8, 2026), the current availability status of Photrexa should be independently verified.”